Aoyama, Daisetsu https://orcid.org/0000-0002-9175-4881
Uzui, Hiroyasu
Sekihara, Takayuki
Eguchi, Tomoya
Hasegawa, Kanae
Tsuji, Toshihiko
Kataoka, Tatsuhiro
Nagao, Moeko
Kakehashi, Shota
Mukai, Moe
Aiki, Takayoshi
Yamaguchi, Junya
Shiomi, Yuichiro
Tama, Naoto
Fukuoka, Yoshitomo
Ishida, Kentaro
Tada, Hiroshi
Funding for this research was provided by:
Daiichi Sankyo Company
Biotronik
Bristol-Myers Squibb
Boehringer Ingelheim
Bayer
ALVAUS
Novartis Pharma
Ono Pharmaceutical
Takeda Pharmaceutical Company
DVx
Article History
Received: 3 January 2022
Accepted: 25 May 2022
First Online: 5 July 2022
Declarations
:
: Hiroshi Tada is a member of Circulation Journal’s editorial team and received honoraria (lecture fees) from Daiichi-Sankyo Co., Ltd., Biotronik Japan, Inc., Bristol-Myers Squibb, and Boehringer Ingelheim and grants from Bayer Yakuhin, Ltd., Japan, Boehringer Ingelheim Japan, ALVAUS Co., Ltd., Novartis Pharmaceuticals Japan, ONO PHARMACEUTICAL CO., LTD, and Takeda Pharmaceutical Company, Ltd. Daisetsu Aoyama, Moe Mukai, and Shota Kakehashi belong to endowed department by Biotronik Japan, Inc., DVx Inc., ALVAUS Co., Ltd. No other authors have any conflicts of interest to disclose.